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Abstract. Ammonia concentrations in exhaled breath (eNH3) and skin gas of
20 healthy subjects were measured on-line with a commercial cavity ring-down
spectrometer and compared to saliva pH and plasma ammonium ion (NH+4 ), urea
and creatinine concentrations. Special attention was given to mouth, nose and skin
sampling procedures and the accurate quantification of ammonia in humid gas samples.
The obtained median concentrations were 688 parts per billion by volume (ppbv) for
mouth-eNH3, 34 ppbv for nose-eNH3, and 21 ppbv for both mouth- and nose-eNH3
after an acidic mouth wash (MW). The median ammonia emission rate from the lower
forearm was 0.3 ng cm−2 minute−1. Statistically significant (p<0.05) correlations
between the breath, skin and plasma ammonia/ammonium concentrations were not
found. However, mouth-eNH3 strongly (p<0.001) correlated with saliva pH. This
dependence was also observed in detailed measurements of the diurnal variation and
the response of eNH3 to the acidic MW. It is concluded that eNH3 as such does not
reflect plasma but saliva and airway mucus NH+4 concentrations and is affected by
saliva and airway mucus pH. After normalization with saliva pH using the Henderson-
Hasselbalch equation, mouth-eNH3 correlated with plasma NH
+
4 , which points to saliva
and plasma NH+4 being linked via hydrolysis of salivary urea.
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21. Introduction
Ammonia (NH3) plays a significant role in the human body and is considered to be an
important biomarker. The molecule has been linked to liver and kidney function and
the effects of exercise [1], bacterial activity [2], halitosis [3] and to being an attractant
for mosquitoes [4]. Ammonia is present in all body fluids, mainly as ammonium ion
(NH+4 ) but also in the form of NH3. In too high concentrations it becomes toxic to the
human body. Thus, for a healthy person, blood ammonia is tightly regulated via the
urea cycle, with excess ammonia being converted to urea and excreted through urine.
The biomarker is usually monitored as NH+4 concentration in blood or, non-invasively,
in urine, saliva, sweat or breath.
Due to its volatile nature, ammonia is present as gaseous NH3 in the air around the
alveolar interface in the lung. It is therefore generally argued that, as for other volatile
biomarkers, it should be possible to detect NH3 concentrations in exhaled breath that
are related to the amount of ammonia present in the blood. During the last decades,
considerable effort has been put into detecting gaseous exhaled breath ammonia (eNH3)
as a surrogate for blood or urine detection [5]. Apart from being non-invasive, this
approach would provide rapid routine diagnostics and continuous monitoring of the
health status, for example, during haemodialysis (HD) or exercise. Being volatile, the
ammonia in the blood is not only released at the alveolar interface but also via the skin,
offering another possibility for non-invasive on-line monitoring of systemic ammonia
levels.
The quantitative (real-time) detection of trace species in exhaled breath and skin
gas requires sophisticated analytical instruments and advanced sampling techniques [6].
Early work on breath ammonia, including diurnal variations (DVs), was done in the
70s using atmospheric pressure ionization mass spectrometry [7]. Since then, newly
emerging techniques such as selected-ion flow-tube mass spectrometry (SIFT-MS) [8–
23], ion-mobility spectroscopy (IMS) [24], optical methods [2, 24–33] and various sensors
[3, 34–40] have been employed to investigate fundamental aspects of breath ammonia
detection, such as the background level in the healthy population. In parallel, clinical
studies have been carried out to explore the potential of eNH3 as biomarker of health
conditions related to end-stage renal failure [8, 26, 32, 33], liver disease [27, 35, 36, 40],
HD efficacy [8, 23, 24, 26, 32, 33, 38] and Helicobacter pylori infection [2, 12]. Two
groups have so far studied the release of ammonia from the skin [18, 41].
While it is intriguing that a single biomarker can provide a wealth of information,
the detected ammonia concentrations may not be easily interpreted. The baseline studies
mentioned above reported a wide range of mouth-exhaled ammonia concentrations for
healthy persons, between 0.1 and 3 parts per million by volume (ppmv), even under
controlled experimental settings, e.g. after fasting. Mixing ratios above 10 ppmv, which
would be difficult to explain physiologically if originating from blood, were observed in
some of the clinical studies [8, 23, 38]. In the majority of these investigations it was
assumed that mouth-exhaled breath ammonia reflects blood ammonia levels. Recently,
3however, several observations have cast doubt on this assumption. Nose-exhaled
ammonia levels were found to be significantly lower than mouth-exhaled concentrations
[19, 20, 30]. Also, it was shown that acidic and alkali mouth washes decrease and
increase eNH3, respectively, and it was hypothesized that this effect might be linked
to changes in oral cavity pH [20, 34]. In addition, the latest clinical studies could not
confirm a correlation between mouth-eNH3 and blood ammonia [27] as well as blood
ammonia and HD status [42]. Thus, some authors have concluded that mouth-eNH3
originates mainly from the oral cavity instead of the alveolar interface [20, 42].
Most of the inconsistencies in the results of the previous ammonia studies are
probably related to the general difficulties associated with the quantitative measurement
of gaseous ammonia in breath and skin gas. These can be summarized as follows:
(i) There are endogenous sources and sinks of ammonia other than the alveolar or skin
interface, such as mucus, saliva and sweat.
(ii) Ammonia is a highly water soluble gas. Since soluble species participate in airway
gas exchange [43, 44], alveolar ammonia concentrations will be subject to change
on their way through lung, airways and oral/nasal cavities.
(iii) Ammonia is a highly reactive species. Once exhaled within the rapidly cooling,
water saturated breath gas, the ammonia molecules will easily ’stick’ to any surfaces
they come in contact with on the way to or inside the measurement apparatus,
leading to adsorption and desorption (so-called memory) effects.
Breath and skin gas ammonia quantification therefore requires extra care concerning
the sampling and measurement procedures. However, not enough attention is usually
paid to breath collection and adsorption/desorption issues. Consequently, while exhaled
breath ammonia has successfully been detected in a fair amount of studies, the exact
source of the measured ammonia has so far not been reliably identified.
The motivation for this work was to define the background level of eNH3 in the
healthy population as precisely as possible and to shed light on the origin of breath
and skin gas ammonia. For this purpose, we measured the concentration of ammonia in
breath exhaled through mouth and nose, in skin gas and in plasma to investigate if there
exists a common source. The obtained values were compared to saliva pH and model-
based headspace estimations to verify the alleged contribution from the oral cavity. In
addition, mouth- and nose-exhaled breath samples were analyzed after the oral cavity
component had been minimized using an acidic mouth wash (MW) to see if alveolar
ammonia concentrations can be accessed in that way. The strong effect of the MW and
the natural daily variation of breath and skin ammonia were explored in detail.
2. Methods
2.1. Human subjects
The subjects were recruited among co-workers and students at the Laboratory of
Physical Chemistry, University of Helsinki. A total of 20 healthy volunteers, 13 men
4and 7 women aged 22 - 61 years and with a mean body mass index (BMI) of 24.0±2.7,
of whom 19 were non-smokers and 1 was smoker, participated in the study. The
subjects were required to fast overnight (for at least 10 hours), refrain from exercise
in the morning before sampling, to wash their right forearm with tap water, and to
minimize physical activity for at least 30 minutes prior to the start of the measurement.
All samples were given in the laboratory between 08:00 and 11:00 in the morning.
Information was asked regarding age, body height and weight, time and nature of the
last meal and/or drink, recent exercise activity, medication, smoking status and the
time of the last cigarette. Five healthy volunteers, three male and two female, aged
between 22 and 49 years, all non-smokers, participated in the diurnal, MW response
and protein intake measurements. The research was approved by the Coordinating
Ethics Committee of the Hospital District of Helsinki and Uusimaa and all volunteers
gave their written informed consent to participate in the study.
2.2. Cavity ring-down spectrometer
A commercial ammonia (and water) analyzer (Picarro, G2103) based on wavelength
scanned cavity ring-down spectroscopy (CRDS) was used for on-line analysis of the
breath samples. CRDS is a common laser-based absorption technique for sensitive and
selective trace gas detection. The high sensitivity is achieved by employing an optical
cavity formed by highly reflective mirrors that enhances the absorption path length and
thus the absorption signal contrast [45].
The optical cavity/sample cell was configured as a folded, three mirror resonator
with a volume of 33 cm3. Two polytetrafluoroethylene (PTFE) particulate filters, one
at the gas inlet of the analyzer and one at the inlet to the cavity, protected the highly
reflective mirrors. The temperature of the instrument casing and the sample cell was
controlled to 48 ◦C, while the sample pressure in the cell was kept at 140 Torr. The
sample flow rate was fixed to 1 standard liter per minute (slpm). The response time
for both a 10-90% rise and a 90-10% fall for 3 ppmv of a dry ammonia standard was
specified as 30 seconds. A precision of 1 and 0.3 parts per billion by volume (ppbv)
was quoted for raw data (measurement interval 1-2 seconds) and 30 seconds running
average, respectively. In the latter mode, we determined a detection limit of 0.3 ppbv.
The operational range of the analyzer was specified to be 0 - 50 ppmv. With the supplied
software, the acquired data could be graphically and numerically monitored in real-time
on an external monitor.
The instrument delivered reasonable NH3 concentrations for outdoor air (down to
0.5 ppbv), indoor air (3-5 ppbv), and indoor air in the presence of humans (8-10 ppbv).
Cross-validation against our home-built CRDS setup [46] yielded comparable mixing
ratios for dry and humidified ammonia gas standards as well as breath samples. The
longer response times of the Picarro analyzer can probably be attributed to memory
effects caused by the PTFE filters. The obtained H2O levels were retrospectively
found to be unphysiologically high. When the instrument was compared to an external
5humidity sensor, an error of about 20% was observed. For this reason, absolute water
concentrations are not given in this work.
2.3. Ammonia quantification issues
With a dimensionless Henry’s law constant of 911 at 37 ◦C [47], ammonia is a highly
water soluble species. Moreover, being a polar molecule it has a propensity for
adsorption to surfaces. In practice, this means that the accuracy and response time (the
time it takes until the true ammonia concentration in the sample is measured) of gaseous
ammonia assessment primarily depends on the sample humidity and the instrument
history, e.g. the difference in NH3 concentration between consecutive measurements.
The walls of the gas transport tubings and the surfaces inside the analytical
instrument may either provide free binding sites for gas-phase ammonia molecules or
act as a reservoir of ammonia molecules. If the gaseous ammonia content increases
beyond a prevailing gas-wall equilibrium concentration, the number of molecules in
the reservoir will increase (adsorption), whereas, if the gas concentration decreases,
ammonia molecules from the walls will enrich the gas (desorption) [48]. In the presence
of water, which is also a polar molecule, the ammonia and water molecules compete for
the same adsorption sites, thereby causing even longer response times to changes in NH3
concentration. Depending on surface material(s) and area, flow rate, sample humidity
and device history, the response time can be minutes to hours [48].
The scenarios described above assume a flow measurement. Under static (stopped
flow) conditions, the difficulties due to adsorption and desorption processes are further
aggravated. This is exemplified by our tests with aluminum coated gas sampling
bags (Delta Analytics, DA 8004). Upon filling an (unheated) bag with a dry
ammonia standard sample (500 ppbv), more than half of the initial concentration
was instantaneously lost to the walls of the bag, followed by a further slow decay.
Filling an (unheated) bag with a humid sample (breath, ca. 500 ppbv) resulted in
immediate loss of most of the ammonia. Heating the bag did not help to resolve these
issues. Similar instantaneous adsorption phenomena were also observed in stainless
steel, quartz-coated stainless steel and PTFE tubings and sample cells when performing
stopped flow measurements.
It is clear that breath sampling bags and closed cell sample analysis cannot be
used in connection with eNH3 quantification. This makes it difficult or even impossible
to store breath samples for later analysis, or to use alternative sampling approaches
recommended for water soluble gases, such as isothermal re-breathing [44, 49]. Instead,
(breath) ammonia analysis is best performed on-line, as a flow measurement, with as
high flow rate and as simple sampling equipment (e.g. minimized surface area, no
breathing mask) as possible. All surfaces that come in contact with the breath gas must
be adequately heated to above body temperature since even the smallest condensation
spot will lead to much longer response times and, likely, to a significant underestimation
of the true ammonia concentration. Further precautions should include the use of inert
6Figure 1. (a) Custom-built PTFE buffer tube (BT) and mouth piece for breath
sampling, (b) on-line mouth-exhaled eNH3 breath sampling through the heated and
heat-isolated BT, (c) custom-built, heated skin gas sampling device with an arithmetic
spiral engraved in the base, (d) on-line skin emission measurement on the lower forearm.
materials, such as PTFE.
2.4. Breath gas sampling
A hollow cylinder made of PTFE was used as a buffer tube (BT) to collect (near) end-
tidal breath samples from mouth and nose (figure 1(a)). The BT had a length of 20 cm,
an outer diameter (OD) of 4 cm and an inner diameter (ID) of 2.6 cm. It included a cap
to which a hollow cylinder PTFE mouthpiece of length 6 cm, OD 1.2 cm and ID 1 cm
was attached. The total buffer volume was 110 cm3. The breath was extracted at the
center of the BT and led to the spectrometer via a 45 cm long 1/8 inch PTFE tubing.
To minimize condensation and subsequent risk for losses and long response times, the
BT and all tubings were heated to about 45 ◦C using resistive heating wires, and isolated
with thermal insulation foam (figure 1(b)).
The buffer tube geometry and volume were designed in such a way that mostly
the end-tidal part of the breath was sampled. More refined means of separating dead
space from end-tidal breath, such as a combination of a non-rebreathing valve and a
capnograph [50], could not be installed because such equipment was not available entirely
made of PTFE. Instead, for both mouth and nose sampling, the volunteers were asked to
breathe continuously into the sampling piece and to perform the in- and exhalations via
the opposite route, i.e. in through the nose and out through the mouth, and in through
7the mouth and out through the nose. A metronome assisted in keeping the respiration
rate at 12 breaths/minute. A dependence of eNH3 on the different combinations of
inhalation/exhalation routes was not observed.
Due to the ammonia gas exchange in the lung and airway mucus, and the expected
contribution from the oral cavity, the eNH3 concentrations should be exhalation flow
rate dependent. Accurate control of tidal volume and exhalation flow rate would thus
be desirable. However, we had to abstain from implementing a flow meter and actively
controlled end-tidal breath sampling to avoid introducing additional surface area in the
sampling apparatus. A rough standardization of the exhalation flow rate was achieved
by stimulating a constant breathing frequency (metronome) and by encouraging normal,
calm breathing.
To obtain a stable signal and one concentration value, continuous breathing for 3-5
minutes was needed because of the relatively slow response of the ammonia analyzer
for humid samples. While faster response time is preferable, it is not necessarily a
disadvantage to measure an average over several exhalations, instead of relying on a
single exhalation. An example trace for a typical mouth-eNH3 measurement can be
seen in figure 2(a). A peak in the beginning of every exhalation due to the oral cavity
contribution in the dead space volume might be expected. Small ripples in accordance
with the breathing frequency can indeed be seen but the resolution of the full individual
breath cycles was prevented by the size of the buffer volume, the measurement speed
(about one point / second) and residual adsorption/desorption effects. A typical nose-
eNH3 measurement is displayed in figure 2(b). The smaller ripples suggest a smaller
difference between dead space and end-tidal ammonia. The overall intra-individual
reproducibility of an eNH3 measurement was estimated to be around 15%, depending
on the prevailing sampling technique.
2.5. Skin gas sampling
The skin gas sampling device was a PTFE cylinder with an OD of 4 cm and a height
of 2.5 cm. It had an arithmetic spiral carved in its base, with a gas inlet at the edge
and an gas outlet in the center (figure 1(c)). The volume of the spiral was 3.6 cm3 and
the area open to the skin was 7.5 cm2. Pure nitrogen at a pressure slightly (ca. 10
Torr) above ambient pressure was flown through the skin sampler as carrier gas, and
the outlet was directly connected to the ammonia analyzer via a 65 cm long 1/8 inch
PTFE tubing. The connectors were made of perfluoroalkoxy (Swagelok, PFA-220-6).
The skin sampler and the tube connection to the analyzer were heated to about 45 ◦C
by resistive heating wires.
Several skin sampling locations on the body were tried. The lower forearm, 5-7 cm
from the wrist, proved to be the most convenient and suitable location because of the
relatively low density of eccrine sweat glands (compared to hands and feet), which are
known to produce sweat containing high ammonia concentrations [4]. In fact, the hands
(or sweat on the hands) were found to continuously emit several hundreds of ppbv (tens
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Figure 2. Ammonia analyzer raw-data (without averaging) for a typical mouth (a),
two consecutive nose (b) and a skin (c) measurement (data from volunteer no. 18).
The skin emission is here given as measured in units of ppbv for comparison. The peak
at the onset of the skin gas sampling is probably due to sweat ammonia.
of ng cm−2 minute−1) of ammonia, hundred times more than the lower forearm.
Before each sampling event, pure nitrogen gas (∼0.7 ppbv ammonia) was flown
through the skin sampler and ammonia analyzer until the background level was 1-2
ppbv. The sampling area was covered with a cap to eliminate room air contamination.
This could take up to 15 minutes. Then the skin sampler was placed on the inner side
of the lower forearm of the subject and carefully tightened with a flexible strap around
the forearm (figure 1(d)). Following this, the sampler was slightly lifted to remove the
cap, after which it was swiftly attached back onto the skin. Care was taken that the
sampler was not moved during the skin gas acquisition. In addition, to avoid sweating
and subsequent additional ammonia excretion, the subjects were asked not to move or
speak, but to relax and stay calm.
A trace of a typical skin emission measurement can be seen in figure 2(c). In the
beginning, there were usually peaks in NH3 and H2O concentrations, probably due to
9sweat. It was found that the NH3 peak can be greatly reduced by washing the skin with
tap water followed by a 30 minute drying and resting period prior to the measurement.
During the 10 minutes sampling period the subjects relaxed until the ammonia emission
stabilized around an apparently constant level, which was taken as the skin emission
value. In preliminary tests it was observed that if the forearm was not washed and/or the
volunteers did not stay calm before or during the measurement the initial peak could be
several hundreds of ppbv high and it took much longer time to reach a constant emission
rate.
The skin ammonia mixing ratio measured in the carrier gas, Sˆ (ppbv), was converted
to skin emission rate, Skin (ng cm−2 minute−1), with the help of the ideal gas law, i.e.
using the relation
Skin =
SˆV pM
RTa
, (1)
where V is the volume flow rate (1 slpm in this study), p the pressure (1 atm), M the
molar mass (17.03 g/mol for ammonia), R the universal gas constant (0.08205746 L atm
K−1 mol−1), T the temperature (306 K for skin) and a is the skin sampling area (7.5
cm2 in this work).
2.6. Saliva sampling and pH measurement
Unstimulated whole saliva was collected on a petri dish and immediately analyzed for
pH. During the background level study, the saliva pH was measured with a compact
hand-held flat-electrode pH-meter (ExTech, EC500), whereas a different unit (Horiba,
D-51) combined with a flat tip ISFET electrode (Horiba, 0014-D00) was used for the DVs
and the MW response measurements. Both devices had an accuracy of 0.02 pH units
and were calibrated on every measurement day and before each measurement series. The
agreement between the two pH-meters was excellent and within the specified accuracy.
Comparable results were also obtained by measuring the pH directly in the mouth (in
the saliva on the tongue) and immediately after the collection of the saliva sample.
2.7. Blood sampling and analysis
Venous blood samples were collected during the examination day (figure 3, phases 5
and 6). Plasma ammonium ion (P-NH+4 ), plasma urea (P-Urea) and plasma creatinine
(P-Crea) were quantified from the samples. For P-NH+4 sampling, one ml of plasma
was collected using a standard needle to a K2-EDTA vacutainer tube (Venosafe,
Terumo, Elkton, MD) on ice without application of tourniquet. P-Urea and P-Crea
samples were collected to Lithium heparin tubes (BD Vacutainer, Frankling Lakes,
NJ). Whole blood samples were immediately centrifuged at 4 ◦C and the separated
plasma was frozen for later analysis, which was performed within four weeks of the
sampling. Biochemical analyses were performed in the accredited Helsinki University
10
1
10
100
1000
0 10 20 30 40 50 60 70
0
2
4
6
8
(a)
 
 
 
N
H
3 
co
nc
en
tra
tio
n 
/ p
pb
v
2
1
3
4
5
6
7
8
(b)
 
 
H
2O
 / 
%
Time / minutes
Figure 3. Typical measurement sequence (data from volunteer no. 18) illustrating
the background level study protocol with the different phases indicated: (1) nitrogen
gas flow, (2) skin emission, (3) nose-exhaled breath, (4) mouth-exhaled breath, (5)
operator nose-exhaled breath, (6) indoor air flow, (7) nose- and mouth-exhaled breath
after the acidic mouth wash, and (8) nitrogen gas flow.
Central Hospital Laboratory (HUSLAB; www.hus.fi), which belongs to the Labquality
Ltd. (www.labquality.fi) national quality assessment program. P-NH+4 was determined
with an enzymatic analysis method (Cobas Integra Ammonia) using the Cobas Integra
400 Plus analyser (Roche Diagnostics, Basel, Switzerland). P-Urea and P-Crea
were determined with the kinetic ultraviolet assay UREA/BUN and the enzymatic
colorimetric test Crea Plus (Roche Diagnostics), respectively. Both analytes were
quantified with a Modular-PPPE-analyser (Hitachi Ltd, Tokyo, Japan). It is important
to note that blood ammonia determination is a complex and challenging procedure.
The major limitations, which are in detail discussed in [51], are connected to the proper
drawing and handling, but also the storage and analysis of the samples.
2.8. Background level study measurement protocol
Figure 3 illustrates the different phases of a single measurement set in the background
level study. After arriving at the laboratory, the subjects first washed their right forearm
with tap water, dried the skin with paper towels and then rested (with a minimum of
physical activity) for 30 minutes. During that time, the instrument was flushed with
nitrogen to provide a low (1-2 ppbv) background ammonia concentration (phase 1).
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After resting, the subjects read and signed the informed consent and filled out
the questionnaire. Then, the skin emission was measured for about 10 minutes (phase
2), after which the inlet was switched to the BT and ambient air was sampled. The
subjects were asked to exhale into the BT through the nose for about 4 minutes, and
after a short break again for 4 minutes (phase 3). After another short break, the subject
performed mouth-exhalations for about 5 minutes (phase 4). Then, the volunteers went
to a separate room to have their saliva collected and the blood samples taken. In the
meantime, the operator of the CRDS spectrometer (one of the authors) performed two
successive nose measurements to spur the removal of ammonia (memory effect from the
subject’s mouth measurement) from the tubings and the Picarro instrument (phase 5).
Then, the instrument was flushed with ambient air for about 15-20 minutes (phase 6).
Upon their return from saliva and blood sampling, the volunteers were asked to first
brush their teeth and then wash their mouth with an acidic mouth wash (concentrated
lemon juice, 1:1 diluted with tap water, pH of 2.45) for 1 minute [34]. After spitting out
the MW and the first stimulated saliva, the subjects immediately gave a nose breath
sample (2-3 minutes), and a mouth breath sample (2-3 minutes). The two measurements
were repeated at least once (phase 7), and the lowest levels were taken as nose-eNH3 and
mouth-eNH3 values after the MW. The whole measurement session took approximately
60 minutes.
The operator nose breathing (phase 5) after the high mouth-eNH3 concentrations
(phase 4) was necessary to establish a gas-wall ammonia equilibrium concentration closer
to the ammonia levels expected in the next volunteer measurement (see section 2.3), and
thereby enable the fast response time required to reliably assess the eNH3 concentrations
after the MW, whose (maximal) effect only lasted a few minutes at most. A correlation
between operator and volunteer eNH3 mixing ratios was not found.
For some volunteers, nose sampling (without MW) was repeated during phase 6,
and this led to the same results as obtained from the first nose measurement in phase 3.
Thus, there are no indications that the nitrogen gas flow (phases 1, 2 and 8) influenced
the obtained nose-eNH3 values, nor that the volunteer mouth or operator nose eNH3
concentrations had an influence on the MW samples.
As a consequence of the high ammonia skin emission rates from the hands (see
section 2.5), latex gloves were worn by all persons, operators as well as volunteers, near
the ammonia analyzer at all times to prevent contamination.
2.9. Data analysis
The ammonia traces measured with the Picarro instrument were examined during or
immediately after the measurements by viewing the traces in the graphical interface.
Usually, the 30 s running average mode was best suited to determine the average
concentration (during a phase with a stable ammonia level). The data were saved
and later re-evaluated.
Correlations between the different measurements (breath, skin, saliva, plasma) and
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comparisons between groups (gender, age, BMI, sampling time, etc.) were assessed
using Spearman’s rank correlation and Mann-Whitney U tests (PASW Statistics 18,
SPSS Inc.), respectively.
2.10. Ammonia and ammonium ion concentrations in a solution
Ammonia is a weak base. For the pH ranges of human blood and saliva, the ratio of
the concentrations of ammonia (cNH3), and ammonium ion (cNH
+
4 ), in a solution is
determined by the Henderson-Hasselbalch equation
pH = pKa + log10
(
cNH3
cNH+4
)
, (2)
where pKa is the acid dissociation coefficient. At 37
◦C, the pKa of ammonia is 8.890
in pure water (also in saliva and sweat) and 9.014 in human plasma [47]. For example,
2.4% of the total ammonia is present as NH3 in blood with a physiological pH of 7.4,
whereas it is 0.9% in saliva with a pH of 6.83, and 0.08% in sweat with a pH of 5.8.
2.11. Estimation of plasma, saliva and sweat headspace ammonia mixing ratios
The partial pressure of a species above a solution depends on the solubility of the species,
which is usually given in terms of Henry’s law constant, either in units of mol L−1 atm−1
(kH) or dimensionless (kHcc), where kHcc=kHRT . The gas-phase NH3 mixing ratio
(cgNH3) above a solution at atmospheric pressure can then be calculated according to
cgNH3 =
cNH3
kH
. (3)
At a temperature of 37 ◦C, the ammonia kH and kHcc values for pure water (also for
saliva and sweat) are 35.8 µmol L−1 atm−1 and 911, respectively, whereas they are 31.9
µmol L−1 atm−1 and 812 for human plasma [47].
Combining equations (2) and (3), using a blood pH of 7.4, and assuming that the
pulmonary capillary plasma NH+4 concentrations lie within the normal arterial/venous
plasma NH+4 concentration range of 10 and 50 µmol/L [51], results in alveolar gas-phase
NH3 concentrations between 8 and 38 ppbv to be expected in the healthy population.
A similar calculation, assuming NH+4 concentrations in whole saliva of 850-5500 µmol/L
[52] and a saliva pH of 6.83, gives 207-1338 ppbv of NH3 to be expected in the headspace
of saliva. The total amount of ammonia in human sweat can vary between 500 and 8000
µmol/L [53]. For thermal sweat with a pH of 5.8 [54], the gaseous NH3 mixing ratio in
the headspace of sweat can thus be estimated to be 11-182 ppbv.
Ammonia headspace concentrations in other compartments, such as the mucus of
the bronchial region, the airways or the nasal cavity could not be estimated due to the
limited information on ammonium ion content and pH of those liquids in the literature.
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Table 1. Compilation of the results of the background level study with 20 volunteers.
The range, mean, median, standard deviation (SD) and the 95% confidence interval
of the mean (ConfInt) are given for the ammonia concentrations obtained in mouth-
and nose-exhaled breath before and after an acidic MW (in units of ppbv), the skin
emission rate (ng cm−2 minute−1), saliva pH, and for the plasma concentrations of
NH+4 (µmol/L), urea (mmol/L) and creatinine (µmol/L).
Min-Max (Range) Mean Median SD ConfInt
Mouth 396-2133 (1737) 775 688 396 589-960
Nose 13-140 (127) 45 34 32 30-60
MouthMW 14-38 (24) 23 21 6 20-26
NoseMW 15-38 (23) 22 21 6 20-25
Skin 0.2-2.9 (2.7) 0.5 0.3 0.6 0.2-0.7
Saliva pH 6.35-7.7 (1.35) 6.84 6.83 0.32 6.78-7.08
P-NH+4 <10-39 (29) 19 17 10 15-24
P-Urea 3.3-7.7 (4.4) 5.0 5.1 1.2 4.5-5.6
P-Crea 56-117 (61) 86 89 17 78-94
3. Results
3.1. Background level study
The results of the background level study (20 subjects) are compiled in table 1. The
table lists the range, mean, median, standard deviation (SD) and the 95% confidence
interval of the mean (ConfInt) of the ammonia mixing ratios obtained for mouth-eNH3
(Mouth), nose-eNH3 (Nose), mouth- (MouthMW) and nose-eNH3 (NoseMW) after the
acidic MW, and for the skin emission rate (Skin). The same statistical parameters are
given for saliva pH and the plasma concentrations of NH+4 (P-NH
+
4 ), urea (P-Urea) and
creatinine (P-Crea).
The highest median value (688 ppbv) was obtained for mouth-eNH3, followed by
nose-eNH3, which was about a factor of twenty lower (34 ppbv). After the MW, the
mixing rations observed in mouth-MW (21 ppbv) and nose-MW (21 ppbv) exhalations
were even lower and essentially equal. A median ammonia mixing ratio in the lower
forearm skin gas of 3.4 ppbv, yet an order of magnitude lower than the nose levels, gave
rise to the median skin emission rate (0.3 ng cm−2 minute−1). The distributions of the
ammonia mixing ratios obtained for the different sampling techniques are depicted as
histograms in figure 4. The distributions were found to be close to log-normal.
The indoor air ammonia concentrations were always clearly below the ammonia
mixing ratios in breath, and the ammonia content of the nitrogen gas was always below
the mixing ratios emitted by the skin. One of the volunteers, who had an extraordinarily
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Figure 4. Distributions of the breath and skin gas ammonia concentrations measured
during the healthy population background level study with 20 subjects. The skin
emission is displayed in units of ppbv for comparison.
high skin emission rate (32 ppbv, 2.9 ng cm−2 minute−1), was later found to suffer from
skin disease psoriasis. This condition or the treatment could explain the high values,
but it should be pointed out that this volunteer also had one of the highest plasma
ammonium ion levels.
The median saliva pH and plasma NH+4 , urea and creatinine values were well within
the normal ranges expected for healthy persons. Unfortunately, for 6 of the subjects,
the plasma ammonium ion concentration was below the detection limit of the enzymatic
analysis method (10 µmol/L) and could not be accurately measured.
Relevant correlations are summarized in table 2. The breath, skin and plasma
values were not significantly correlated. On the other hand, very strong (p<0.001)
correlations were found between MouthMW and NoseMW and Mouth and saliva pH. A
strong (p<0.01) correlation also existed between Nose and P-Crea. Moderate (p<0.05)
correlations were found between P-Crea and age, Nose and NoseMW, and BMI and
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Table 2. Relevant strong (p<0.01) and moderate (p<0.05) correlations found between
the measured data. The parameter rs is Spearman’s rank correlation coefficient.
Strong correlations rs Moderate correlations rs
MouthMW ←→ NoseMW 0.94 P-Crea ←→ Age 0.48
Mouth ←→ Saliva pH 0.85 Nose ←→ NoseMW 0.45
Nose ←→ P-Crea 0.68 P-NH+4 ←→ MouthNorm 0.45
Skin ←→ NoseNorm 0.58 P-NH+4 ←→ BMI 0.45
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Figure 5. (a) Diurnal variations (DVs) of mouth-exhaled breath ammonia during a
normal day (circular markers) with breakfast (B), lunch (L) and coffee (C), and, on
a different day, while fasting (triangular markers), (b) saliva pH corresponding to the
normal day mouth-exhaled breath DV. All data from a single subject (male, age 36),
who has been fasting for 10 hours prior to the start of the measurements.
P-NH+4 . A strong correlation was also found between Mouth and Mouth water. It is
unclear, whether this correlation is of instrumental or physiological origin.
In order to normalize the mouth- and nose-exhaled ammonia values to the median
saliva pH (6.83), they were multiplied by the factor 10(6.83-pH), derived from equation
(2), where pH is the saliva pH of the individual subject. After normalization, a strong
correlation appeared between normalized nose (NoseNorm) and Skin values, and a
moderate correlation between normalized mouth (MouthNorm) and P-NH+4 .
The comparison between groups revealed that female volunteers, who were younger
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on average (28 years), had lower P-Crea (p=0.001) than their male counterparts (36
years), and lower nose-eNH3 (p=0.1) values. Also, those who exercised the day before
the measurement had lower mouth-eNH3 (p=0.004), lower Mouth water (p=0.01) and
lower saliva pH (p=0.04) levels. The volunteers who ate protein-rich food the day
before the measurement had higher P-Urea (p=0.02) and Skin water content (p=0.03).
In general, skin and mouth water levels were higher the later (closer to lunch) the
measurement was performed, but otherwise no significant correlation with the time of
measurement was found.
3.2. Diurnal variations
To be able to relate the results of the background level study to the typical variations
of breath and skin ammonia of healthy persons during the course of a day, several
DVs were measured. The trace with circular markers in panel (a) of figure 5 shows a
representative DV (single person) of mouth-exhaled ammonia during a normal working
day including breakfast (B), lunch (L) and coffee (C), and in panel (b) the corresponding
saliva pH values. The trace with triangular markers in panel (a) represents the DV of
mouth-exhaled ammonia without food and drink (except water) intake.
Clearly, and in contrast to the results of our recent breath HCN study [50], eNH3
decreases significantly after food and drink intake, whereas the baseline shows a gradual
increase over the day. This correlates well with saliva pH. The reason for the initial
increase in saliva pH after food/drink intake is presently unknown. It might be connected
to saliva sampling, i.e. increased saliva flow rate after eating and/or collection of
stimulated saliva from a particular saliva gland instead of whole, unstimulated saliva.
The eNH3 and pH levels recovered about 2 hours after food/drink intake.
Figure 6 presents the DVs of nose-exhaled ammonia (square markers) and skin
emission (circular markers) measured on the same day. The times of breakfast, lunch and
coffee are again indicated. The trace with triangular markers shows the skin emission
from a different day without food and drink intake. Qualitatively and quantitatively
similar DVs as displayed in figures 5 and 6 have been measured with the same volunteer
on different days and with other subjects (data not shown).
3.3. Response to the acidic mouth wash
Since the acidic lemon juice mouth wash had a significant effect on the eNH3
concentrations, we investigated the response of eNH3 to the MW after fasting and
tooth brushing. Figure 7 depicts mouth-exhaled ammonia values (circular markers in
panel (a)) and the corresponding saliva pH values (panel (b)). The time of the MW is
indicated. The square markers in panel (a) show the breath values after normalization
with saliva pH via the Henderson-Hasselbalch equation. A qualitatively similar response
was obtained for nose-exhaled breath (data not shown).
Evidently, the observed reduction in mouth-eNH3 after MW was similar as for the
volunteers during the background level study. The lowest eNH3 and pH values were
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Figure 6. Diurnal variations of nose-exhaled breath (square markers) and skin
emission (circular markers) ammonia during a normal day with breakfast (B), lunch
(L) and coffee (C), and, on a different day, skin emission while fasting (triangular
markers). All data from a single subject (male, age 36), who has been fasting for 10
hours prior to the start of the measurements.
again maintained only for a couple of minutes before the main pH buffer systems in the
oral cavity (saliva bicarbonate, protein and phosphate concentrations) started to bring
the saliva pH back to normal values. Even immediate saliva pH analysis after the MW
did not show as low values as the pH of the lemon juice due to the fast response of the
buffer systems. As after food or drink intake, the overall recovery time was about 2
hours.
4. Discussion
4.1. Mouth-exhaled breath ammonia
The median mouth-exhaled ammonia concentration obtained in the present background
level study was significantly higher than the median nose mixing ratio and the median
mouth and nose concentrations after the acidic MW. The mouth-eNH3 values were
also much higher than the theoretically expected alveolar levels. Although parameters
such as food and drink intake, measurement time and exercise were controlled, the
distribution of mouth-eNH3 values (figure 4) was relatively wide (396-2133 ppbv).
The observed diurnal variation of mouth-exhaled ammonia (figure 5) is similar to
previously published data [3, 7, 55] and confirms that overnight fasting prior to the
background level measurements was indeed necessary for standardization. The gradual
increase in mouth-eNH3 during the day is probably related to the corresponding increase
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Figure 7. (a) Response of mouth-eNH3 to the acidic lemon juice mouth wash (MW,
applied after 75 minutes) that was employed in the background level study (circular
markers), and the corresponding saliva pH normalized ammonia concentrations (square
markers), (b) corresponding saliva pH response to the MW. All data from a single
subject (male, age 36), who has been fasting for 10 hours prior to the start of the
measurements. A qualitatively similar response was obtained for nose-eNH3.
in saliva pH, which might be part of a natural circadian rhythm. In general, both the
DV and the response after the acidic MW exhibit a clear dependence on saliva pH.
The lack of correlation of mouth-eNH3 with P-NH
+
4 but significant correlation with
saliva pH suggests that the latter is an important factor in determining mouth-eNH3.
However, as shown for the MW response (figure 7), where the normalization with saliva
pH does not yield a constant mouth-eNH3 level, and exemplified by a negative correlation
between MouthNorm and saliva pH in the background level study, at least one other
factor must be involved, most likely a change in absolute saliva NH+4 concentration.
One of the main sources of salivary NH+4 is the break down of salivary urea by
bacteria [52]. The saliva NH+4 concentration thus depends on parameters such as
the type and number of bacteria in the saliva, the saliva urea concentration and the
saliva flow rate. The wide inter- and intra-individual distribution of the mouth-exhaled
ammonia mixing ratios, and the minima after food/drink intake and MW, may therefore
be explained by variations in saliva pH and salivary NH+4 . After the acidic MW, the
distribution is narrower because saliva pH has decreased and almost all ammonia resides
in saliva in the form of NH+4 .
Using equations (2) and (3) and the appropriate coefficient of Henry’s law, the saliva
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NH+4 concentration corresponding to the median mouth-eNH3 mixing ratio obtained in
the background level study was calculated to be 2828 µmol/L. This result is in excellent
agreement with the mean (whole) saliva NH+4 level previously determined in the healthy
population (2574 µmol/L) [52], and further advocates the hypothesis that the principle
source of mouth-eNH3 is salivary NH
+
4 .
Several additional, exploratory experiments were performed to support the line of
argumentation discussed above.
(i) The flow-rate dependence of mouth-eNH3 was confirmed by conducting exhalations
with considerably lower and higher than normal flow rates, which yielded higher
and lower ammonia concentrations, respectively.
(ii) Alongside with the lemon juice mixture, several commercial MWs were tested for
their capability of reducing the oral ammonia contribution. As in [34], the MW
effect scaled inversely with MW pH. The concentrated lemon juice had the lowest
pH and thus the largest and longest effect in reducing mouth-eNH3.
(iii) Unstimulated, whole saliva was collected in a petri dish directly after a mouth-
eNH3 measurement and immediately analyzed for gas emission with the help of the
sampler used for the skin gas measurements. The ammonia concentrations found
in the headspace of the saliva were comparable to the corresponding mouth-eNH3
concentrations, and to the headspace values predicted in section 2.11.
(iv) A one minute exposure to 5 ppmv ammonia in air (inhaled from a sampling bag)
did not lead to any increase in mouth-eNH3 detected immediately afterwards.
The inhaled eNH3 is probably absorbed in the upper airways [56]. This suggests
that typical ambient air ammonia levels will not have an effect on exhaled breath
ammonia.
(v) The intake of protein-rich food (60 g) after fasting did not show a clear and
reproducible effect on mouth- or nose exhaled ammonia mixing ratios.
The assumption that mouth-eNH3 originates to a large extent from salivary NH
+
4
and is affected by saliva pH is valid even in the case of end-tidal breath collection
because the breath nevertheless has to pass the oral cavity, where it is enriched with
ammonia. Thus, mouth-eNH3 cannot, in general, be recommended for direct assessment
of systemic ammonia levels. Yet, there might be an indirect relation between plasma
NH+4 and breath NH3 via the hydrolysis of salivary urea, which, as is well known,
correlates strongly, independently of saliva flow rate, and quite instantaneously, with
plasma urea [57]. Plasma urea, in turn, depends on plasma ammonia via the urea
cycle. The correlation between MouthNorm and P-NH+4 observed in the background
level study is an indication for this possibility.
It should be noted that the (near end-tidal) mouth-eNH3 concentrations obtained
in the present work lie well within the range of mouth-eNH3 levels reported in previous
studies on healthy subjects, albeit with a relatively narrow concentration distribution.
Some groups have obtained a slightly higher median concentration [15, 18, 21, 35],
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whereas others have measured considerably lower values [5, 23, 25, 28, 36, 40]. However,
as should be clear by now, such comparisons can be misleading because the same
instrumental NH3 reading can be obtained for significantly different original eNH3
concentrations, depending on the prevailing sampling and measurement procedures.
For example, a low exhalation flow rate (more enrichment due to saliva) in combination
with losses due to adsorption can give rise to the same measured eNH3 mixing ratio as
does a high exhalation flow rate (less enrichment due to saliva) together with memory
effects in the instrument.
4.2. Nose-exhaled breath ammonia and mouth wash effect
The median nose-exhaled breath ammonia concentration is a factor of twenty lower
than the median mouth-exhaled mixing ratio, and lower than the nose-eNH3 levels
reported in previous studies [19, 20, 30]. While it cannot be excluded that ammonia is
absorbed in the nasal cavity, it is more likely that nose-NH3 is less enriched by saliva
headspace NH3. For some subjects, the breathing route was still open to and influenced
by the oral cavity, whereas others were breathing ’purely’ through the nose, probably
by instinctively closing the soft palate. This reasoning explains the relatively wide nose-
NH3 distribution (figure 4) compared to the measurements after the MW. It is confirmed
by the fact that for the subgroup of subjects with the highest Nose values, mouth- and
nose-NH3 correlated, while the subgroup with the lowest Nose values had equal Nose
and NoseMW mixing ratios.
The diurnal variation of nose-eNH3 presented in figure 6 shows a similar pattern as
the DV of mouth-eNH3 (figure 5), with clear dips after food and drink intake, because
the particular volunteer obviously did not completely close the soft palate. Less variation
can be expected for ’pure’ nose breathing. The correlation between gender and plasma
creatinine can probably be explained by the fact that creatinine production in the body
is proportional to the muscle mass [58]. Also, females were younger on average and had
lower nose-NH3 levels, hence the rather strong correlation between Nose and P-Crea.
Intriguingly, after minimizing the oral contribution with the acidic MW, the
distributions of mouth- and nose-eNH3 values (figure 4) are narrow, basically equal,
and exactly in the range predicted for the alveolar NH3 levels. However, the individual
values do not correlate with the corresponding P-NH+4 concentrations. The reason might
be that (pure) Nose, NoseMW and MouthMW all depend on mucus NH+4 and pH, i.e.
on tracheo-bronchial gas exchange [44], rather than on alveolar NH3. As in the case of
saliva, the tracheo-bronchial lining fluids may have a complex relationship with plasma
NH+4 .
The possibility for gas exchange between the nasal and oral cavities, the probable
influence of mucus and lining fluids, and the overall lack of correlations with plasma
ammonia found in the present study, suggest that, for the healthy population, it is
difficult to assess systemic ammonia levels directly by nose breathing or after using an
acidic MW.
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4.3. Hypothesis - Clinical studies
Several clinical studies reported significantly elevated mouth-exhaled ammonia levels in
patients with renal or kidney malfunction, and a decrease to ’normal’ levels following
HD treatment [8, 23, 24, 26, 32, 33, 36, 38]. The pre-HD mouth-eNH3 concentrations
in excess of 10 ppmv obtained in some of these studies [8, 23, 38] are, however, too high
to be physiologically meaningful. If directly originating from plasma, an eNH3 mixing
ratio of 10 ppmv would translate to a P-NH+4 concentration of 13 mmol/L, which is far
above the levels normally measured in these patients (0.15 mmol/L). In general, plasma
NH+4 levels exceeding 1 mmol/L (corresponding to 0.76 ppmv alveolar NH3) are unusual
and occur only under conditions of acute hyperammonemia [51].
In the light of the results of the present investigation, we would like to stress the
possibility that the mouth-eNH3 concentrations observed in the clinical studies are, as
for the healthy population, almost entirely determined by oral factors. This hypothesis
is supported by two observations, first, the general inconsistencies in the results of the
clinical studies, and, second, the documented high values of salivary urea and pH of
patients with renal and kidney malfunction prior to HD, and their decrease during HD
treatment [59–62].
Some authors have found a correlation between mouth-eNH3 and blood urea
nitrogen (BUN) during HD treatment [24, 26, 38]. In contrast, no relation between
mouth-eNH3 and arterial NH
+
4 was seen in patients with hepatic encephalopathy [27].
Also, no significant difference in blood ammonia before and after HD was found in
patients with chronic kidney disease (CKD), and a correlation between blood ammonia
and severity of CKD could not be established [42]. At the same time, it was shown that
oral factors are different in patients with kidney disease before and after HD [59–63].
Salivary urea and pH are substantially elevated before HD, stay constant or increase
slightly during HD, and are significantly lower after HD. Moreover, salivary urea, NH+4
and pH [63], as well as BUN and salivary urea nitrogen [64] correlated in patients with
CKD.
To illustrate, in the study by Bots et al [60], salivary urea decreased by a factor
of 5 in patients with end-stage renal disease undergoing HD. Assuming that pre-HD
saliva NH+4 levels are elevated by a similar factor compared to ’normal’ values, and a
pre-HD saliva pH of 7.3 [60], this would imply a gaseous NH3 concentration in saliva
headspace of around 10 ppm, and could well explain the high pre-HD mouth-eNH3 levels
observed in such patients. In fact, with the saliva pH values measured by Bots et al ,
even the small peak in mouth-eNH3 during HD observed by [23, 26] can be explained
(by a corresponding peak in saliva pH). Thus, it seems that oral NH+4 and pH are by
far not negligible but instead the dominating factors determining eNH3, even in clinical
situations.
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4.4. Ammonia emitted from skin
Given the median ammonia skin emission of 3.4 ppbv at a gas flow rate of 1 slpm
and with a sampling area of 7.2 cm2, the median skin emission rate was 0.3 ng cm−2
minute−1. This corresponds well to the 0.34 ng cm−2 minute−1 measured for healthy
volunteers by Nose et al , who employed a similar skin sampler and sampling location
[41]. Using a different skin sampling technique (the headspace of the whole forearm,
including the hand, was accumulated in a Nalophan bag for 7 minutes), Turner et al
observed mixing ratios in the low ppm range [18]. A significant increase in ammonia
skin emission after intake of high-protein food and a corresponding correlation with
plasma NH+4 was reported by Nose et al [41]. In the present work, the skin ammonia
emission after protein intake (60 g, overnight fasting) was measured several times and
with several volunteers, but an ammonia peak could not confidently be reproduced.
There is a clear difference in the diurnal variation of skin ammonia (figure 6) when
fasting (almost constant, slightly decreasing) and during normal food intake (gradual
increase). Since a direct connection between protein intake and skin values could not
be observed in separate measurements, one explanation for the gradual increase could
be a circadian variation of the body temperature due to metabolism after food intake,
and subsequent increased release of sweat containing ammonia.
In general, the emission of ammonia from the skin can be explained either by
diffusion directly from plasma or by ammonia in sweat. Sweat ammonia, in turn, has
three possible origins, (i) blood (skin/sweat pH is normally lower than blood pH, and
the resulting pH gradient makes blood ammonia diffuse to the skin), (ii) the sweat gland
(ammonia may diffuse both outwards to skin and inwards to blood), and (iii) hydrolysis
of sweat urea by skin bacteria [54]. Previous research has excluded (iii) but is still
divided whether most of the sweat ammonia originates from plasma [53, 65, 66] or the
sweat glands [54]. Of the three types of sweat glands (eccrine, apocrine and sebaceous),
eccrine glands, which have the highest density on palms and soles, then in decreasing
order on head, trunk and extremities, produce most sweat ammonia [4]. Choosing the
lower forearm as sampling location was part of our strategy to minimize what we believe
is contamination from sweat.
The real-time NH3 skin emission sampling approach proved to be highly sensitive,
even when measuring on the forearm. Heavy breathing, talking and the slightest
movements, immediately increased the detected ammonia mixing ratios dramatically.
In the evening of a day with normal food intake or after physical activity, the initial
peaks and ’constant’ values could easily reach levels around 1 ppmv and 100 ppbv,
respectively. The systemic plasma NH+4 concentrations are normally stable and change
slowly. It is thus unlikely that the observed high and quickly changing skin emission
rates are dominated by direct diffusion from blood. Accordingly, in the present work, a
direct correlation between skin ammonia emission and plasma NH+4 was not found for
healthy volunteers after fasting. The correlation between Skin and NoseNorm could,
however, indicate that the skin emission is indirectly linked to systemic values, maybe
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Figure 8. Approximate ammonia levels at different locations in the body. (a) Plasma
NH+4 [51], (b) NH3 at the alveolar interface (calculated from [51]), (c) lung and airway
mucus (not known), (d) salivary NH+4 [52], (e) saliva headspace NH3 (calculated from
[52] and measured in this work), (f) nose-exhaled NH3 (measured in this work), (g)
mouth-exhaled NH3 (measured in this work), (h) sweat headspace NH3 (calculated
from [53] and measured in this work), (i) sweat NH+4 [53], (j) skin NH3 emission rate
(measured in this work).
via sweat.
4.5. Summary - ammonia levels in the healthy human body
A summary of the results of this work and the findings of others is schematically
presented in figure 8. The following scenario for the fate of ammonia in breath is
suggested: Upon inhalation, the ambient air, typically containing a few ppbv of ammonia
at most, participates in gas exchange with oral/nasal cavity and respiratory system
fluids. Depending on the actual concentration differences between the gas and the
fluids, ammonia is absorbed or released. At the alveolar interface, the end-tidal air
may acquire some tens of ppbv of gaseous NH3, corresponding to the headspace of
plasma ammonia, while the dead space volume continues to interact with the ammonia
reservoir in airways. During exhalation, the end-tidal breath again participates in the
gas exchange with the lung and airway mucus before it passes the oral cavity, where it
is enriched with the ammonia in the headspace of saliva. Much lower concentrations
are exhaled through the nose because there is little or no gas exchange with the oral
cavity, and after decreasing the oral cavity pH with an acidic MW, because most of the
ammonia is then trapped as NH+4 in the saliva.
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4.6. Outline and outlook
Although the response of the commercial CRDS analyzer was not fast enough to resolve
the individual breath cycles, the overall performance was satisfactory. It should be
mentioned that the protocol used in the background level study was relatively complex,
spanning three orders of magnitude of ammonia mixing ratios and involving several
different breath and skin measurements to be conducted within an hour around the
blood sampling. If only one type of breath measurement would be performed, e.g. only
nose-eNH3 or only mouth-eNH3, the response time would be faster and subjects could
be analyzed every 10-15 minutes.
The following general recommendations for standardized eNH3 measurements can
be made: (i) abstain from breath collection to sampling bags and from stopped flow
measurements, (ii) use on-line flow sample analysis with flow rates not much lower than
1 slpm, (iii) use simple sampling equipment and inert materials heated to above body
temperature, (iv) ensure a relatively high and constant exhalation flow rate, (v) use
(pure) nose-eNH3 sampling or an acidic MW if the aim is to minimize the oral cavity
NH3 contribution, and (vi) perform a complementary saliva pH measurement if the aim
is to access salivary NH+4 .
For future eNH3 studies, technical improvements should include exhalation flow
rate and volume control, simultaneous CO2 measurement, improved response time (e.g.
by eliminating the particulate filters) and improved sensitivity of plasma NH+4 analysis.
Larger clinical studies could then be carried out to confirm the eNH3 baseline and
pH dependence for a wider population, and to further investigate the source of eNH3
from nose and after the MW (bronchial or alveolar gas exchange). A follow-up study
to directly prove the relation between mouth-NH3 and salivary NH
+
4 is presently under
way. Real-time monitoring of breath and skin ammonia before, during and after exercise
could shed light on the origin of skin ammonia and the effect of exercise on systemic
ammonia levels.
5. Conclusions
Without doubt, the reliable quantification of breath and skin ammonia requires
extraordinary measures concerning sampling, sample handling and quantification
procedures. Using fast, on-line analysis in combination with simple, carefully
designed sampling equipment, reproducible and consistent results were obtained with a
commercial ammonia analyzer based on cavity ring-down laser absorption spectroscopy.
We have shown that mouth-eNH3 does not directly reflect plasma NH
+
4
concentrations in the healthy population, but strongly depends on individual saliva
pH. Although the present study does not directly prove that the main origin of mouth-
eNH3 is salivary NH
+
4 , it provides strong evidence for this assumption. It is likely that
the mouth-eNH3 concentrations obtained in recent clinical studies can, to a large extent,
be explained by the saliva NH+4 and saliva pH levels of the patients. Salivary NH
+
4 could
REFERENCES 25
be linked to plasma NH+4 via bacterial hydrolysis of salivary urea.
Little influenced by oral factors, nose breath sampling and the use of an acidic MW
seem to be promising eNH3 sampling techniques. In fact, employing these methods
resulted in eNH3 levels within the theoretically expected alveolar concentration range
in the healthy population. However, the lack of correlation with plasma NH+4 suggests
airway gas exchange to play a significant role. In clinical studies, (pure) nose-eNH3 could
be useful in resolving alveolar NH3 concentrations stemming from elevated plasma NH
+
4
levels. The factor dominating the skin ammonia emission appears to be local sweat
gland or muscle production rather than direct diffusion of systemic plasma NH+4 .
Acknowledgments
We thank all study participants. Laboratory technician Tuula Soppela is acknowledged
for her skillful technical assistance. The authors would like to thank the Academy
of Finland for financial support (projects 135126 and 132174). The study was
also supported by Folkha¨lsan Research Foundation (P.-H.G) and Wilhelm and Else
Stockmann Foundation (P.-H.G., M.L.).
References
[1] Wilkinson D J, Smeeton N J and Watt P W 2010 Ammonia metabolism, the brain
and fatigue; revisiting the link Prog. Neurobiol. 91 200-19
[2] Kearney D J, Hubbard T and Putnam D 2002 Breath ammonia measurement in
Helicobacter pylori infection Digest. Dis. Sci. 47 2523-30
[3] Toda K, Li J and Dasgupta P K 2006 Measurement of ammonia in human breath
with a liquid-film conductivity sensor Anal. Chem. 78 7284-91
[4] Smallegange R C, Verhulst N O and Takken W 2011 Sweaty skin: an invitation
to bite? Trends Parasitol. 27 143-8
[5] Hibbard T and Killard A J 2011 Breath ammonia analysis: Clinical application
and measurement CRC Cr. Rev. Anal. Chem. 41 21-35
[6] Kim K-H, Jahan S A and Kabir E 2012 A review of breath analysis for diagnosis
of human health TrAC-Trend. Anal. Chem. 33 1-8
[7] Lovett A M, Reid N M, Buckley J A, French J B and Cameron D M 1979 Real-time
analysis of breath using an atmospheric-pressure ionization mass-spectrometer
Biomed. Mass Spectrom. 6 91-7
[8] Davies S, Sˇpaneˇl P and Smith D 1997 Quantitative analysis of ammonia on the
breath of patients in end-stage renal failure Kidney Int. 52 223-8
[9] Sˇpaneˇl P, Davies S and Smith D 1998 Quantification of ammonia in human breath
by the selected ion flow tube analytical method using H30
+ and 0+2 precursor ions
Rapid Commun. Mass Spectrom. 12 763-6
REFERENCES 26
[10] Smith D, Sˇpaneˇl P and Davies S 1999 Trace gases in breath of healthy volunteers
when fasting and after a protein-calorie meal: a preliminary study J. Appl. Physiol.
87 1584-8
[11] Diskin A M, Sˇpaneˇl P and Smith D 2003 Time variation of ammonia, acetone,
isoprene and ethanol in breath: a quantitative SIFT-MS study over 30 days
Physiol. Meas. 24 107-19
[12] Penault C, Sˇpaneˇl P and Smith D 2005 Detection of H-pylori infection by breath
ammonia following urea ingestion In: Amann A, Smith D (eds.) Breath Analysis
for Clinical Diagnosis and Therapeutic Monitoring (Singapore: World Scientific)
393-9
[13] Smith D, Wang T, Sˇpaneˇl P and Bloor R 2006 The increase of breath ammonia
induced by niacin ingestion quantified by selected ion flow tube mass spectrometry
Physiol. Meas. 27 437-44
[14] Sˇpaneˇl P, Turner C, Wang T S, Bloor R and Smith D 2006 Generation of volatile
compounds on mouth exposure to urea and sucrose: implications for exhaled
breath analysis Physiol. Meas. 27 N7-17
[15] Turner C, Sˇpaneˇl P and Smith D 2006 A longitudinal study of ammonia, acetone
and propanol in the exhaled breath of 30 subjects using selected ion flow tube
mass spectrometry, SIFT-MS Physiol. Meas. 27 321-37
[16] Sˇpaneˇl P, Dryahina K and Smith D 2007 Acetone, ammonia and hydrogen cyanide
in exhaled breath of several volunteers aged 4-83 years J. Breath Res. 1 011001
[17] Sˇpaneˇl P, Dryahina K and Smith D 2007 The concentration distributions of some
metabolites in the exhaled breath of young adults J. Breath Res. 1 026001
[18] Turner C, Parekh B, Walton C, Sˇpaneˇl P, Smith D and Evans M 2008 An
exploratory comparative study of volatile compounds in exhaled breath and
emitted by skin using selected ion flow tube mass spectrometry Rapid Commun.
Mass Spectrom. 22 526-32
[19] Wang T S, Pysanenko A, Dryahina K, Sˇpaneˇl P and Smith D 2008 Analysis of
breath, exhaled via the mouth and nose, and the air in the oral cavity J. Breath
Res. 2 037013
[20] Smith D, Wang T, Pysanenko A and Sˇpaneˇl P 2008 A selected ion flow tube mass
spectrometry study of ammonia in mouth- and nose-exhaled breath and in the
oral cavity Rapid Commun. Mass Spectrom. 22 783-9
[21] Enderby B, Lenney W, Brady M, Emmett C, Sˇpaneˇl P and Smith D 2009
Concentrations of some metabolites in the breath of healthy children aged 7-
18 years measured using selected ion flow tube mass spectrometry (SIFT-MS) J.
Breath Res. 3 036001
[22] Boshier P R, Cushnir J R, Priest O H, Marczin N and Hanna G B 2010 Variation in
the levels of volatile trace gases within three hospital environments: implications
for clinical breath testing J. Breath Res. 4 031001
REFERENCES 27
[23] Endre Z H, Pickering J W, Storer M K, Hu W P, Moorhead K T, Allardyce R,
McGregor D O and Scotter J M 2011 Breath ammonia and trimethylamine allow
real-time monitoring of haemodialysis efficacy Physiol. Meas. 32 115-30
[24] Neri G, Lacquaniti A, Rizzo G, Donato N, Latino M and Buemi M 2012 Real-
time monitoring of breath ammonia during haemodialysis: use of ion mobility
spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques
Nephrol. Dial. Transplant. 27 2945-52
[25] Moskalenko K L, Nadezhdinskii A I and Adamovskaya I A 1996 Human breath
trace gas content study by tunable diode laser spectroscopy technique Infrared
Phys. Techn. 37 181-92
[26] Narasimhan L R, Goodman W and Patel C K 2001 Correlation of breath ammonia
with blood urea nitrogen and creatinine during hemodialysis Proc. Natl. Acad. Sci.
U S A 98 4617-21
[27] DuBois S, Eng S, Bhattacharya R, Rulyak S, Hubbard T, Putnam D and Kearney
D J 2005 Breath ammonia testing for diagnosis of hepatic encephalopathy Digest.
Dis. Sci. 50 1780-4
[28] Manne J, Sukhorukov O, Ja¨ger W and Tulip J 2006 Pulsed quantum cascade
laser-based cavity ring-down spectroscopy for ammonia detection in breath Appl.
Opt. 45 9230-7
[29] Stamyr K, Vaittinen O, Jaakola J, Guss J, Metsa¨la¨ M, Johanson G and Halonen L
2009 Background levels of hydrogen cyanide in human breath measured by infrared
cavity ring down spectroscopy Biomarkers 14 285-91
[30] Hibbard T and Killard A J 2011 Breath ammonia levels in a normal human
population study as determined by photoacoustic laser spectroscopy J. Breath
Res. 5 037101
[31] Lewicki R, Kosterev A A, Thomazy D M, Risby T H, Solga S, Schwartz T B and
Tittel F K 2011 Real time ammonia detection in exhaled human breath using
a distributed feedback quantum cascade laser based sensor Proc. of SPIE 7945
http://dx.doi.org/10.1117/12.874887
[32] Popa C, Dutu D, Cernat R, Matei C, Bratu A, Banita S and Dumitras D 2011
Ethylene and ammonia traces measurements from the patients’ breath with renal
failure via LPAS method Appl. Phys. B 105 669-74
[33] Wang J, Xie H, Liang L, Zhang W, Peng W and Yu Q 2012 Tunable fiber
laser based photoacoustic spectrometer for breath ammonia analysis during
hemodialysis Laser Phys. 22 327-30
[34] Norwood D M, Wainman T, Lioy P J and Waldman J M 1992 Breath ammonia
depletion and its relevance to acidic aerosol exposure studies Arch. Environ. Health
47 309-13
[35] Wakabayashi H, Kuwabara Y, Murata H, Kobashi K and Watanabe A 1997
REFERENCES 28
Measurement of the expiratory ammonia concentration and its clinical significance
Metab. Brain Dis. 12 161-9
[36] Shimamoto C, Hirata I and Katsu K 2000 Breath and blood ammonia in liver
cirrhosis Hepato-gastroenterol. 47 443-5
[37] Timmer B, Olthuis W and Berg A 2005 Ammonia sensors and their applications:
a review Sensor. Actuat. B-Chem 107 666-77
[38] Ishida H, Satou T, Tsuji K, Kawashima N, Takemura H, Kosaki Y, Shiratori S
and Agishi T 2008 The breath ammonia measurement of the hemodialysis with a
QCM-NH3 sensor Biomed. Mater. Eng. 18 99-106
[39] Gouma P, Kalyanasundaram K, Yun X, Stanacevic M and Wang L S 2010
Nanosensor and breath analyzer for ammonia detection in exhaled human breath
IEEE Sensors J. 10 49-53
[40] Adrover R, Cocozzella D, Ridruejo E, Garca A, Rome J and Podesta´ J 2012
Breath-ammonia testing of healthy subjects and patients with cirrhosis Digest.
Dis. Sci. 57 189-95
[41] Nose K, Mizuno T, Yamane N, Kondo T, Ohtani H, Araki S and Tsuda T 2005
Identification of ammonia in gas emanated from human skin and its correlation
with that in blood Anal. Sci. 21 1471-4
[42] Imran M, Shah Y, Nundlall S, Roberts N B and Howse M 2012 Is blood ammonia
influenced by kidney function? A prospective study Clin. Biochem. 45 363-5
[43] Anderson J C, Babb A L and Hlastala M P 2003 Modeling soluble gas exchange
in the airways and alveoli Ann. Biomed. Eng. 31 1402-22
[44] King J, Unterkofler K, Teschl G, Teschl S, Koc H, Hinterhuber H and Amann A
2011 A mathematical model for breath gas analysis of volatile organic compounds
with special emphasis on acetone J. Math Biol. 63 959-99
[45] Berden G and Engeln R (eds.) 2009 Cavity Ring-Down Spectroscopy: Techniques
and Applications (New York: Wiley-Blackwell)
[46] Schmidt FM, Vaittinen O, Metsa¨la¨ M, Kraus P and Halonen L 2010 Direct
detection of acetylene in air by continuous wave cavity ring-down spectroscopy
Appl. Phys. B 101 671-82
[47] Lang W, Blo¨ck T M and Zander R 1998 Solubility of NH3 and apparent pK of
NH+4 in human plasma, isotonic salt solutions and water at 37 degrees C Clin.
Chim. Acta 273 43-58
[48] Schmohl A, Miklos A and Hess P 2001 Effects of adsorption-desorption processes
on the response time and accuracy of photoacoustic detection of ammonia Appl.
Opt. 40 2571-8
[49] O’Hara M E, O’Hehir S, Green S and Mayhew C A 2008 Development of a
protocol to measure volatile organic compounds in human breath: a comparison
of rebreathing and on-line single exhalations using proton transfer reaction mass
spectrometry Physiol. Meas. 29 309-30
REFERENCES 29
[50] Schmidt F M, Metsa¨la¨ M, Vaittinen O and Halonen L 2011 Background levels and
diurnal variations of hydrogen cyanide in breath and emitted from skin J. Breath
Res. 5 046004
[51] Barsotti R J 2001 Measurement of ammonia in blood J. Pediatr. 138 S11-20
[52] Huizenga J R, Vissink A, Kuipers E J and Gips C H 1999 Helicobacter pylori and
ammonia concentrations of whole, parotid and submandibular/sublingual saliva
Clin. Oral Investig. 3 84-7
[53] Sato K 1977 The physiology, pharmacology, and biochemistry of the eccrine sweat
gland Rev. Phys., Biochem. Pharmacol. 79 51-131
[54] Brusilow S W and Gordes E H 1968 Ammonia secretion in sweat Am. J. Physiol.
214 513-7
[55] Vaittinen O, Schmidt F M, Metsa¨la¨ M and Halonen L 2012 Exhaled breath
biomonitoring using laser spectroscopy Curr. Anal. Chem. CAC-EPUB-20120906-
11
[56] Meulenbelt J 2012 Ammonia Medicine 40 94-5
[57] Cardoso E M L, Arregger A L, Tumilasci O R, Elbert A and Contreras L N 2009
Assessment of salivary urea as a less invasive alternative to serum determinations
Scand. J. Clin. Lab. Inv. 69 330-4
[58] Baxmann A C, Ahmed M S, Marques N C, Menon V B, Pereira A B, Kirsztajn G
M and Heilberg I P 2008 Influence of muscle mass and physical activity on serum
and urinary creatinine and serum cystatin C Clin. J. Am. Soc. Nephro. 3 348-54
[59] Kho H-S, Lee S-W, Chung S-C and Kim Y-K 1999 Oral manifestations and
salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease
undergoing hemodialysis Oral Surg. Oral Med. O. 88 316-9
[60] Bots C P, Brand H S, Veerman E C I, Valentijn-Benz M, Henskens Y M C,
Valentijn R M, Vos P F, Bijlsma J A, Ter Wee P M, Van Amerongen B M and
Nieuw Amerongen A V 2007 Acute effects of hemodialysis on salivary flow rate
and composition Clin. Nephrol. 67 25-31
[61] Toma´s I, Marinho J S, Limeres J, Santos M J, Arau´jo L and Diz P 2008 Changes
in salivary composition in patients with renal failure Arch. Oral Biol. 53 528-32
[62] Bayraktar G, Kurtulus I, Kazancioglu R, Bayramgurler I, Cintan S, Bural C,
Bozfakioglu S, Issever H and Yildiz A 2009 Oral health and inflammation in
patients with end-stage renal failure Periton. Dialysis Int. 29 472-9
[63] Mydlik M and Derzsiova´ K 2008 Oxalic acid as a uremic toxin J. Renal Nutr. 18
33-9
[64] Raimann J G, Kirisits W, Gebetsroither E, Carter M, Callegari J, Rosales L, Levin
N W and Kotanko P 2011 Saliva urea dipstick test: application in chronic kidney
disease Clin. Nephrol. 76 23-8
[65] Emrich H M and Oelert H 1966 pH-Wert und Gesamtammoniak im menschlichen
Schweiss Pflug. Arch. Ges. Phys. 290 311-4
REFERENCES 30
[66] Czarnowski D, Go´rski J, Jo´z´wiuk J and Boron´-Kaczmarska A 1992 Plasma
ammonia is the principal source of ammonia in sweat Eur. J. Appl. Physiol. Occup.
Physiol. 65 135-7
